Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements
- PMID: 2112470
- DOI: 10.1007/BF00842777
Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements
Abstract
A kinetic method is described for the estimation of neuroreceptor density as well as the rate constants for association and dissociation of rapidly equilibrating radioligands. The method is exemplified by positron emission tomographic measurements of the human brain using 11C-raclopride, a D 2 dopamine receptor antagonist, and 11C-Ro 15-1788, a benzodiazepine receptor antagonist. Using a linear non iterative algorithm, regional binding characteristics were calculated and displayed pixel by pixel in brain maps. Data from repeated experiments on the same subject with different amounts of the unlabeled ligand were utilized. The binding characteristics were determined according to a two step procedure in which the time course of the free radioligand concentration was estimated from a reference region considered to be free of specific receptor binding sites. Alternative methods to determine the concentration of free radioligand are discussed.
Similar articles
-
Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457.Neuroimage. 2002 Sep;17(1):47-60. doi: 10.1006/nimg.2002.1152. Neuroimage. 2002. PMID: 12482067 Clinical Trial.
-
Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.J Cereb Blood Flow Metab. 1989 Oct;9(5):696-708. doi: 10.1038/jcbfm.1989.98. J Cereb Blood Flow Metab. 1989. PMID: 2528555
-
Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.Neuroimage. 1999 Feb;9(2):235-42. doi: 10.1006/nimg.1998.0401. Neuroimage. 1999. PMID: 9927552
-
Recent advances in psychiatric brain imaging.Acta Radiol Suppl. 1990;374:113-5. Acta Radiol Suppl. 1990. PMID: 1966956 Review.
-
Raclopride, a new selective ligand for the dopamine-D2 receptors.Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5):559-68. doi: 10.1016/0278-5846(88)90001-2. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 2975809 Review.
Cited by
-
Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography.Mol Imaging Biol. 2005 Nov-Dec;7(6):411-21. doi: 10.1007/s11307-005-0022-3. Mol Imaging Biol. 2005. PMID: 16328648
-
Estimating neurotransmitter kinetics with ntPET: a simulation study of temporal precision and effects of biased data.Neuroimage. 2008 Feb 1;39(3):1162-79. doi: 10.1016/j.neuroimage.2007.09.046. Epub 2007 Oct 5. Neuroimage. 2008. PMID: 18023364 Free PMC article.
-
Selection of weighting factors for quantification of PET radioligand binding using simplified reference tissue models with noisy input functions.Phys Med Biol. 2012 Feb 7;57(3):609-29. doi: 10.1088/0031-9155/57/3/609. Epub 2012 Jan 12. Phys Med Biol. 2012. PMID: 22241524 Free PMC article.
-
Characterization of [3H]nemonapride binding to mouse brain dopamine D2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies.J Neural Transm Gen Sect. 1994;97(2):119-33. doi: 10.1007/BF01277948. J Neural Transm Gen Sect. 1994. PMID: 7873122
-
A simple method for the quantification of benzodiazepine receptors using iodine-123 iomazenil and single-photon emission tomography.Eur J Nucl Med. 1996 Jul;23(7):782-91. doi: 10.1007/BF00843707. Eur J Nucl Med. 1996. PMID: 8662117
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials